Evidence map›Paper›PMID 39622870›Full record

ArticleScientific reports2024

Development of a novel gut microphysiological system that facilitates assessment of drug absorption kinetics in gut.

Tomoki Imaoka, Reiko Onuki-Nagasaki, Hiroshi Kimura, Kempei Tai, Mitsuharu Ishii, Ayaka Nozue, Ikuko Kaisaki, Misa Hoshi, Kengo Watanabe, Kazuya Maeda and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Tomoki ImaokaDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
Reiko Onuki-NagasakiInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8572, Ibaraki, Japan.
Hiroshi KimuraMicro/Nano Technology Center, Tokai University, 4-1-1 Kitakaname, Hiratsuka, 259-1292, Kanagawa, Japan.
Kempei TaiGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo- ku, Tokyo, 113-0033, Japan.
Mitsuharu IshiiInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8572, Ibaraki, Japan.
Ayaka NozueInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8572, Ibaraki, Japan.
Ikuko KaisakiGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo- ku, Tokyo, 113-0033, Japan.
Misa HoshiDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
Kengo WatanabeDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan.
Kazuya MaedaKitasato University School of Pharmacy, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.
Takashi KamizonoTokyo Ohka Kogyo Co. Ltd, Samukawa-machi, Koza-gun, Tabata, 1590, 253-0114, Kanagawa, Japan.
Takahiro YoshiokaTokyo Ohka Kogyo Co. Ltd, Samukawa-machi, Koza-gun, Tabata, 1590, 253-0114, Kanagawa, Japan.
Takashi FujimotoTokyo Ohka Kogyo Co. Ltd, Samukawa-machi, Koza-gun, Tabata, 1590, 253-0114, Kanagawa, Japan.
Taku SatohInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8572, Ibaraki, Japan.
Hiroko NakamuraMicro/Nano Technology Center, Tokai University, 4-1-1 Kitakaname, Hiratsuka, 259-1292, Kanagawa, Japan.
Osamu AndoInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8572, Ibaraki, Japan.
Hiroyuki KusuharaGraduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo- ku, Tokyo, 113-0033, Japan.
Yuzuru ItoInstitute of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8572, Ibaraki, Japan. ito.yuzuru.fe@u.tsukuba.ac.jp.

Funding

The Japanese Agency for Medical Research and Development JP17be0304204, JP17be0304101, P22be1004101 and JP22be1004301
6 · The paper itself

Abstract

There is an urgent need for novel methods that can accurately predict intestinal absorption of orally administered drugs in humans. This study aimed to evaluate the potential of a novel gut microphysiological system (MPS), gut MPS/Fluid3D-X, to assess the intestinal absorption of drugs in humans. The gut MPS/Fluid3D-X model was constructed using a newly developed flow-controllable and dimethylpolysiloxane-free MPS device (Fluid3D-X

Indexed as

Intestinal AbsorptionBiological TransportCytochrome P-450 CYP3AEpithelial CellsHumansInduced Pluripotent Stem CellsIntestinal MucosaIntestine, SmallKineticsMicrophysiological SystemsModels, BiologicalQuinidineSulfasalazineCytochrome P-450 CYP3AQuinidineSulfasalazine

Identifiers

PMID39622870
PMCPMC11612460

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.